EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Gaush Meditech's enterprise value is HK$2,745.0 Mil.
Gaush Meditech's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-207.8 Mil. Therefore, Gaush Meditech's EV-to-EBITDA for today is -13.21.
The historical rank and industry rank for Gaush Meditech's EV-to-EBITDA or its related term are showing as below:
HKSE:02407'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -27.36 Med: -20.59 Max: 784.57
Current: -13.21
During the past 5 years, the highest EV-to-EBITDA of Gaush Meditech was 784.57. The lowest was -27.36. And the median was -20.59.
HKSE:02407's EV-to-EBITDA is ranked worse than 100% of 488
companies
in the Medical Devices & Instruments industry
Industry Median: 16.145
vs HKSE:02407: -13.21
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Gaush Meditech EV-to-EBITDA Historical Data
The historical data trend for Gaush Meditech's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Gaush Meditech's EV-to-EBITDA
For the Medical Devices subindustry, Gaush Meditech's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gaush Meditech's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gaush Meditech's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Gaush Meditech's EV-to-EBITDA falls into.
Gaush Meditech EV-to-EBITDA Calculation
Gaush Meditech's EV-to-EBITDA for today is calculated as:
Gaush Meditech's current Enterprise Value is HK$2,745.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gaush Meditech's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-207.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Gaush Meditech's PE Ratio for today is calculated as:
Gaush Meditech's share price for today is HK$19.70.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gaush Meditech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.279.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Gaush Meditech's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Gaush Meditech Ltd is a provider of a broad spectrum of ophthalmic medical devices. The segments of the company include 1) Proprietary products segment develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; 2) Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; 3) Technical services segment provides warranty services, maintenance services and after-sales services related consumables; and 4) Others segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02407 has been successfully added to your